Systemic Diseases with Oral Manifestations and Their Impact on Health-Related Quality of Life

1. Haag DG, Peres KG, Balasubramanian M, Brennan DS. Oral Conditions and Health-Related Quality of Life: A Systematic Review. J Dent Res 2017;96(8):864-74.10.1177/002203451770973728581891 Search in Google Scholar

2. Tackmann E, Dettmer S. Health-related quality of life in adult heart-transplant recipients-a systematic review. Herz 2020;45(5):475-82.10.1007/s00059-018-4745-830191263 Search in Google Scholar

3. Gift HC, Atchison KA. Oral health, health, and healthrelated quality of life. Med Care 1995;33(11): NS57– NS77.10.1097/00005650-199511001-000087475433 Search in Google Scholar

4. Yeoh, S.C., Hua, H., Yepes, J.F., Peterson, D.E. (2018). Contemporary Oral Medicine. New York, USA: Springer, Cham. Search in Google Scholar

5. Gaddey HL. Oral manifestations of systemic disease. Gen Dent 2017;65(6):23-9. Search in Google Scholar

6. Mulliken RA, Casner MJ. Oral manifestations of systemic disease. Emerg Med Clin N Am 2000;18(3):565-75.10.1016/S0733-8627(05)70144-9 Search in Google Scholar

7. World Health Organization (WHO). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 1993;2(2):153-9.10.1007/BF00435734 Search in Google Scholar

8. Kolotkin RL, Andersen JR. A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life. Clin Obes 2017;7(5):273-89.10.1111/cob.12203560009428695722 Search in Google Scholar

9. Paterson C. Quality of life measures. Br J Gen Pract 2010;60(570):53.10.3399/bjgp10X482121280178620040170 Search in Google Scholar

10. Čanković S, Nikolić E, Čanković D, Radić I, Harhaji S. Quality of Life - Theoretical Approach. J Health Care 2011;40(5):1-6.10.5937/ZZ1105001C Search in Google Scholar

11. Baiju RM, Peter E, Varghese NO, Sivaram R. Oral Health and Quality of Life: Current Concepts. J Clin Diagnost Res 2017;11(6):21-6.10.7860/JCDR/2017/25866.10110553549828764312 Search in Google Scholar

12. Strömbeck B, Ekdahl C, Manthorpe R, Wikström I, Jacobsson L. Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000;29(1):20-8.10.1080/03009740075000176110722254 Search in Google Scholar

13. Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy 2017;15(2):127-37.10.1007/s40258-017-0310-5534308028194657 Search in Google Scholar

14. Gelber, R. (1995). Measuring disease: a review of disease- specific quality of life measurement scales. Philadelphia, USA: Open University Press. Search in Google Scholar

15. Huang CI, Lee JL, Ketheeswaran P, Jones CM, Revicki DA, Wu AW. Does personality affect health-related quality of life? A systematic review. PLoS One 2017;12(3):e0173806.10.1371/journal.pone.0173806537132928355244 Search in Google Scholar

16. Haraldstad K, Wahl A, Andenæs R, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res 2019;28(10):2641-50.10.1007/s11136-019-02214-9676125531187410 Search in Google Scholar

17. Bansback N, Harrison M, Brazier J, et al. Health state utility values: a description of their development and application for rheumatic diseases. Arthritis Rheum 200815;59(7):1018-26.10.1002/art.2381318576311 Search in Google Scholar

18. Meregaglia M, Nicod E, Drummond M. The estimation of health state utility values in rare diseases: overview of existing techniques. Int J Technol Assess Health Care 2020;36(5):469-73.10.1017/S026646232000066532981547 Search in Google Scholar

19. Centers for Disease Control and Prevention. Measuring healthy days: Population assessment of health-related quality of life. Centers for Disease Control and Prevention, Atlanta, Georgia, 2000. Search in Google Scholar

20. Fuente Hernández, J., Carmen Aguilar Díaz, F. & Carmen Villanueva Vilchis, M. (2015). Emerging Trends in Oral Health Sciences and Dentistry (1st ed.). Rijeka, Croatia:InTech. Search in Google Scholar

21. Bagramian, R.A. (2002). Oral Health Related Quality of Life. Illinois, USA: Quintessence Publishing Co. Inc. Search in Google Scholar

22. Schmalz G, Patschan D, Schmickler J, et al. Oral healthrelated quality of life in different rheumatic diseases. Oral Dis 2020;26(8):1783-92.10.1111/odi.1346432510714 Search in Google Scholar

23. Gift HC, Atchison KA, Dayton CM. Conceptualizing oral health and oral health related quality of health. Soc Sci Med 1997;44(5):601-8.10.1016/S0277-9536(96)00211-09032828 Search in Google Scholar

24. Slade, G.D. (2002). Oral Health-Related Quality of Life. Illinois, USA: Quintessence Publishing Co. Inc. Search in Google Scholar

25. Stancić I, Sojić LT, Jelenković A. Adaptation of Oral Health Impact Profile (OHIP-14) index for measuring impact of oral health on quality of life in elderly to Serbian language. Vojnosanit Pregl 2009;66(7):511-5.10.2298/VSP0907511S19678573 Search in Google Scholar

26. Bennadi D, Reddy CV. Oral health related quality of life. J Int Soc Prev Community Dent 2013;3(1):1-6.10.4103/2231-0762.115700389409824478972 Search in Google Scholar

27. McGrath C, Broder H, Wilson-Genderson M. Assessing the impact of oral health on the life quality of children: Implications for research and practice. Community Dent Oral Epidemiol 2004;32:81-5.10.1111/j.1600-0528.2004.00149.x15061856 Search in Google Scholar

28. Casamassimo PS, Flaitz CM, Hammersmith K, Sangvai S, Kumar A. Recognizing the Relationship Between Disorders in the Oral Cavity and Systemic Disease. Pediatr Clin N Am 2018;65(5):1007-32.10.1016/j.pcl.2018.05.00930213346 Search in Google Scholar

29. Saccucci M, Di Carlo G, Bossù M, Giovarruscio F, Salucci A, Polimeni A. Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management. J Immunol Res 2018;1-6.10.1155/2018/6061825599427429977929 Search in Google Scholar

30. Meijer JM, Meiners PM, Huddleston Slater JJR, et al. Health-related quality of life, employment and disability in patients with Sjögren’s syndrome. Rheumatology 2009; 48(9):1077-82.10.1093/rheumatology/kep14119553376 Search in Google Scholar

31. Bayetto K, Logan RM. Sjögren’s syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 2010;55:39-47.10.1111/j.1834-7819.2010.01197.x20553243 Search in Google Scholar

32. Bolstad AI, Skarstein K. Epidemiology of Sjögren’s syndrome – from an oral perspective. Curr Oral Health Rep 2016;3:328-36.10.1007/s40496-016-0112-0510479227891302 Search in Google Scholar

33. Cartee DL, Maker S, Dalonges D, Manski MC. Sjögren’s Syndrome: Oral Manifestations and Treatment, a Dental Perspective. J Dent Hyg 2015;89(6):365-71. Search in Google Scholar

34. Serrano J, López-Pintor RM, Fernández-Castro M, et al. Oral lesions in patients with primary Sjögren’s syndrome. A case-control cross-sectional study. Med Oral Patol Oral Cir Bucal 2020;25(1):137-43.10.4317/medoral.23254698299231880282 Search in Google Scholar

35. Błochowiak K, Olewicz-Gawlik A, Polańska A, et al. Oral mucosal manifestations in primary and secondary Sjögren syndrome and dry mouth syndrome. Postepy Dermatol Alergol 2016;33(1):23-7.10.5114/pdia.2016.57764479306026985175 Search in Google Scholar

36. Fernández-Martínez G, Zamora-Legoff V, Hernández Molina G. Oral health-related quality of life in primary Sjögren’s syndrome. Reumatol Clin 2020;16(2 Pt 1):92-6.10.1016/j.reumae.2018.04.001 Search in Google Scholar

37. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 2010;69(6):1103-9.10.1136/ard.2009.110619293702219561361 Search in Google Scholar

38. Seror R, Bowman SJ, Brito-Zeron P, et al. EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015;1(1):e000022.10.1136/rmdopen-2014-000022461315926509054 Search in Google Scholar

39. Meiners PM, Arends S, Brouwer E, Spijkervet FK. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren’s syndrome treated with rituximab. Ann Rheum Dis 2012;71(8):1297-302.10.1136/annrheumdis-2011-20046022258489 Search in Google Scholar

40. Lackner A, Stradner MH, Hermann J, et al. Assessing health-related quality of life in primary Sjögren’s syndrome- The PSS-QoL. Semin Arthritis Rheum 2018;48(1):105-10.10.1016/j.semarthrit.2017.11.00729395257 Search in Google Scholar

41. Lendrem D, Mitchell S, McMeekin P, et al. Health-related utility values of patients with primary Sjögren’s syndrome and its predictors. Ann Rheum Dis 2014;73(7):1362-8.10.1136/annrheumdis-2012-20286323761688 Search in Google Scholar

42. D’Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007;369(9561):587-96.10.1016/S0140-6736(07)60279-717307106 Search in Google Scholar

43. Menzies S, O’Shea F, Galvin S, Wynne B. Oral manifestations of lupus. Ir J Med Sci 2018;187(1):91-3.10.1007/s11845-017-1622-z28470356 Search in Google Scholar

44. Brennan MT, Valerin MA, Napenas JJ, Lockhart PB. Oral manifestations of patients with lupus erythematosus. Dent Clin N Am 2005;49(1):127-41.10.1016/j.cden.2004.07.00615567365 Search in Google Scholar

45. Fortuna G, Brennan MT. Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dent Clin N Am 2013;57(4):631-55.10.1016/j.cden.2013.06.00324034070 Search in Google Scholar

46. Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res 2011;63(0 11):413-9.10.1002/acr.20636343775422588761 Search in Google Scholar

47. Wang SL, Hsieh E, Zhu LA, Wu B, Lu LJ. Comparative Assessment of Different Health Utility Measures in Systemic Lupus Erythematosus. Sci Rep 2015;5:13297.10.1038/srep13297454399026293686 Search in Google Scholar

48. Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390(10103):1685-99.10.1016/S0140-6736(17)30933-928413064 Search in Google Scholar

49. Jung S, Martin T, Schmittbuhl M, Huck O. The spectrum of orofacial manifestations in systemic sclerosis: A challenging management. Oral Dis 2017;23(4):424-39.10.1111/odi.1250727196369 Search in Google Scholar

50. Puzio A, Przywara-Chowaniec B, Postek-Stefańska L, Mrówka-Kata K, Trzaska K. Systemic sclerosis and its oral health implications. Adv Clin Exp Med 2019;28(4):547-54.10.17219/acem/7684730079996 Search in Google Scholar

51. Onesti MG, Fioramonti P, Carella S, Fino P, Marchese C, Scuderi N. Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells. Stem Cells Int 2016;2016:2416192.10.1155/2016/2416192473641926880939 Search in Google Scholar

52. Philipone E, Yoon AJ, Zegarelli D. Intraoral telangiectasias associated with Raynaud disease: A report of two cases. Quintessence Int 2010;41(1):17-20.10.4103/0975-8844.103488 Search in Google Scholar

53. Nascimento IS, Bonfa E, de Carvalho JF, et al. Clues for previously undiagnosed connective tissue disease in patients with trigeminal neuralgia. Clin Rheumatol 2010;15(5):205-8.10.1097/RHU.0b013e3181e928e620661065 Search in Google Scholar

54. Ferreira E, Christmann RB, Borba EF, Borges CT, Siqeira JT, Bonfa E. Mandibular function is severely impaired in systemic sclerosis patients. J Orofac Pain 2010;24(2):197-202. Search in Google Scholar

55. Park EH, Strand V, Oh YJ, Song YW, Lee EB. Healthrelated quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 2019;21(1):61.10.1186/s13075-019-1842-x637771430770765 Search in Google Scholar

56. Reay N. The quality of life in patients with diffuse and limited systemic sclerosis. PhD thesis, University of Leeds, 2008. Search in Google Scholar

57. Raymakers AJ, Tsao NW, Marra CA, Clements PJ, Khanna D. Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association? J Rheumatol 2016;43(10):1832-7.10.3899/jrheum.160162 Search in Google Scholar

58. Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res 2016;308(8):539-51.10.1007/s00403-016-1667-227349424 Search in Google Scholar

59. González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol 2019;(96):121-30.10.1016/j.oraloncology.2019.07.01231422203 Search in Google Scholar

60. Mutafchieva MZ, Draganova-Filipova MN, Zagorchev PI, Tomov GT. Oral Lichen Planus - Known and Unknown: a Review. Folia Med 2018;60(4):528-35.10.2478/folmed-2018-001731188760 Search in Google Scholar

61. Dalirsani, Z., Delavarian, Z., Javadzade-Bolouri, A., et al. (2011). Psychiatric disorders - worldwide advances. Rijeka, Croatia: InTech. Search in Google Scholar

62. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13(4):350-65.10.1177/15441113020130040512191961 Search in Google Scholar

63. Bagan JV, Eisen D, Scully C. The diagnosis and management of oral lichen planus: a consensus approach. Oral Biosci Med 2004;1:21-7. Search in Google Scholar

64. Chiang CP, Yu-Fong Chang J, Wang YP, Wu YH, Lu SY, Sun A. Oral lichen planus - Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management. J Formos Med Assoc 2018;117(9):756-65.10.1016/j.jfma.2018.01.02129472048 Search in Google Scholar

65. González-Moles MÁ, Warnakulasuriya S, González- Ruiz I, et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis 2020.10.1111/odi.1332332144836 Search in Google Scholar

66. Babu A, Chellaswamy S, Muthukumar S, Pandey B, Jayaraj M, Francis S. Bullous Lichen Planus: Case Report and Review. J Pharm Bioallied Sci 2019;11(2): S499–S506.10.4103/JPBS.JPBS_58_19655537531198396 Search in Google Scholar

67. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V oral lichen planus: clinical features and management. Oral Dis 2005;11:338–49.10.1111/j.1601-0825.2005.01142.x16269024 Search in Google Scholar

68. Wiriyakijja P, Porter S, Fedele S, et al. Health-related quality of life and its associated predictors in patients with oral lichen planus: a cross-sectional study. Int Dent J 2020;71(2):140-52.10.1111/idj.12607927531632875594 Search in Google Scholar

69. Wiriyakijja P, Fedele S, Porter SR, Mercadante V, Ni Riordain R. Patient-reported outcome measures in oral lichen planus: A comprehensive review of the literature with focus on psychometric properties and interpretability. J Oral Pathol Med 2018;47(3):228-39.10.1111/jop.1260428622422 Search in Google Scholar

70. Wiriyakijja P, Porter S, Fedele S, et al. The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life. Clin Oral Invest 2020.10.1007/s00784-020-03695-633201359 Search in Google Scholar

71. Tavakolpour S, Mahmoudi H, Mirzazadeh A, et al. Pathogenic and protective roles of cytokines in pemphigus: A systematic review. Cytokine 2020;129:155026.10.1016/j.cyto.2020.15502632058276 Search in Google Scholar

72. Ghaedi F, Etesami I, Aryanian Z, et al. Drug-induced pemphigus: A systematic review of 170 patients. Int Immunopharmacol 2021;92:107299.10.1016/j.intimp.2020.10729933418246 Search in Google Scholar

73. Kasperkiewicz M, Ellebrecht CT, Takahashi H, et al. Pemphigus. Nat Rev Dis Primers 2017;(3):17026.10.1038/nrdp.2017.26590173228492232 Search in Google Scholar

74. Swinson B, Witherow H, Norris P, Lloyd T. Oral manifestations of systemic diseases. Hosp Med 2004;65(2):92-9.10.12968/hosp.2004.65.2.1206714997776 Search in Google Scholar

75. Davenport S, Chen SY, Miller AS. Pemphigus vulgaris: clinicopathologic review of 33 cases in the oral cavity. Int J Periodontics Restorative Dent 2001;21(1):85-90. Search in Google Scholar

76. Sebaratnam DF, Hanna AM, Chee SN, et al. Development of a quality-of-life instrument for autoimmune bullous disease: The Autoimmune Bullous Disease Quality of Life questionnaire. JAMA Dermatol 2013;149(10):1186-91.10.1001/jamadermatol.2013.497223925444 Search in Google Scholar

77. Hajdu K, Brodszky V, Stalmeier PFM, et al. Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus. J Eur Acad Dermatol Venereol 2019;33(11):2106-13.10.1111/jdv.1576531265151 Search in Google Scholar

78. Bagan J, Lo Muzio L, Scully C. Mucosal disease series. Number III. Mucous membrane pemphigoid. Oral Dis 2005;11(4):197-218.10.1111/j.1601-0825.2005.01140.x15984952 Search in Google Scholar

79. Bilgic A, Aydin F, Sumer P, et al. Oral health related quality of life and disease severity in autoimmune bullous diseases. Niger J Clin Pract 2020;23(2):159-64.10.4103/njcp.njcp_216_19 Search in Google Scholar

80. Saleh MA, Zaraa I, Doss N, Saleh NA, Murrell DF. Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires. An Bras Dermatol 2019;94(4):399-404.10.1590/abd1806-4841.20197198700703231644610 Search in Google Scholar

81. Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21(8):1982-92.10.1097/MIB.0000000000000392451168526154136 Search in Google Scholar

82. Adam H, Alqassas M, Saadah OI, Mosli M. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients. J Epidemiol Glob Health 2020;10(4):298-303.10.2991/jegh.k.200330.001775885032959603 Search in Google Scholar

83. Jajam M, Bozzolo P, Niklander S. Oral manifestations of gastrointestinal disorders. J Clin Exp Dent 2017;9(10):1242-8.10.4317/jced.54008569415529167716 Search in Google Scholar

84. Kumar KM, Nachiammai N, Madhushankari GS. Association of oral manifestations in ulcerative colitis: A pilot study. J Oral Maxillofac Pathol 2018;22(2):199-203.10.4103/jomfp.JOMFP_223_16609737330158772 Search in Google Scholar

85. Cao Q, Huang YH, Jiang M, Dai C. The prevalence and risk factors of psychological disorders, malnutrition and quality of life in IBD patients. Scand J Gastroenterol 2019;54(12):1458-66.10.1080/00365521.2019.169789731791216 Search in Google Scholar

86. Marinelli C, Savarino E, Inferrera M, et al. Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients. Gastroent Res Pract 2019;2019:5354320.10.1155/2019/5354320672145231531015 Search in Google Scholar

87. Malinowski KP, Kawalec P. Health utility of patients with Crohn’s disease and ulcerative colitis: a systematic review and meta-analysis. Expert Rev Pharm Out 2016;16(4):441-53.10.1080/14737167.2016.1190644 Search in Google Scholar

88. Telega G, Bennet TR, Werlin S. Emerging new clinical patterns in the presentation of celiac disease. Arch Pediatr Adolesc Med 2008;162(2):164-8.10.1001/archpediatrics.2007.3818250242 Search in Google Scholar

89. Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr 2014;168(3):272-8.10.1001/jamapediatrics.2013.385824395055 Search in Google Scholar

90. Deepak C, Berry N, Vaiphei K, Dhaka N, Sinha SK, Kochhar R. Quality of life in celiac disease and the effect of gluten-free diet. JGH Open 2018;2(4):124-8.10.1002/jgh3.12056620704630483576 Search in Google Scholar

91. Casellas F, Rodrigo L, Molina-Infante J, et al. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) Survey, a specific questionnaire to measure quality of life in patients with celiac disease. Rev Esp Enferm Dig 2013;105(10):585-93.10.4321/S1130-01082013001000003 Search in Google Scholar

92. Long RG, Hlousek L, Doyle JL. Oral manifestations of systemic diseases. Mt Sinai J Med 1998;65(5-6):309-15. Search in Google Scholar

93. Grando LJ, Mello AL, Salvato L, Brancher AP, Del Moral JA, Steffenello-Durigon G. Impact of leukemia and lymphoma chemotherapy on oral cavity and quality of life. Spec Care Dentist 2015;35(5):236-42.10.1111/scd.1211325963973 Search in Google Scholar

94. Harreiter J, Roden M. Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019). Wien Klin Wochenschr 2019;131(1):6-15.10.1007/s00508-019-1450-430980151 Search in Google Scholar

95. Stanisic D, Obradovic R, Vujovic S, Jovanovic M, Zivkovic V. The Connection of Periodontal Disease and Diabetes Mellitus: The Role of Matrix Metalloproteinases and Oxidative Stress. Ser J Exp Clin Res 2019.10.2478/sjecr-2019-0051 Search in Google Scholar

96. Leite RS, Marlow NM, Fernandes JK, Hermayer K. Oral health and type 2 diabetes. Am J Med Sci 2013;345(4):271-3.10.1097/MAJ.0b013e31828bdedf362328923531957 Search in Google Scholar

97. Kesić L, Petrović D, Obradović R, Gasić J, Todorović K. Diabetes mellitus and periodontal disease. Med Pregl 2009;62(11-12):534-8.10.2298/MPNS0912534K Search in Google Scholar

98. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ, CDC Periodontal Disease Surveillance workgroup. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012;91(10):914-20.10.1177/002203451245737322935673 Search in Google Scholar

99. Obradović R, Kesić L, Mihailović D, Jovanović G, Antić S, Brkić Z. Low-level lasers as an adjunct in periodontal therapy in patients with diabetes mellitus. Diabetes Technol Ther 2012;14(9):799-803.10.1089/dia.2012.0027342933022928615 Search in Google Scholar

100. Palamenghi L, Carlucci MM, Graffigna G. Measuring the Quality of Life in Diabetic Patients: A Scoping Review. J Diabetes Res 2020;2020:5419298.10.1155/2020/5419298726134232566680 Search in Google Scholar

101. Cervino G, Terranova A, Briguglio F, et al. Diabetes: Oral Health Related Quality of Life and Oral Alterations. Biomed Res Int 2019;2019:5907195.10.1155/2019/5907195644230731011577 Search in Google Scholar

102. Zhang P, Brown MB, Bilik D, Ackermann RT, Li R, Herman WH. Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35(11):2250-6.10.2337/dc11-2478347690622837369 Search in Google Scholar

103. Hayes A, Arima H, Woodward M, et al. Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study. Value Health 2016;19(1):36-41.10.1016/j.jval.2015.10.01026797234 Search in Google Scholar

104. Khalaf MW, Khader R, Cobetto G, Yepes JF, Karounos DG, Miller CS. Risk of adrenal crisis in dental patients: results of a systematic search of the literature. J Am Dent Assoc 2013;144(2):152-60.10.14219/jada.archive.2013.009423372131 Search in Google Scholar

105. Tucci V, Sokari T. The clinical manifestations, diagnosis, and treatment of adrenal emergencies. Emerg Med Clin N Am 2014;32(2):465-84.10.1016/j.emc.2014.01.00624766944 Search in Google Scholar

106. Pala A, Chowbey R, Sonvanshi N, Patel D, Shah A, Venkatesh A. A review on oral manifestations of systemic diseases. Int J Oral Health Med Res 2016;2(6):131-2. Search in Google Scholar

107. Meyer G, Koch M, Herrmann E, Bojunga J, Badenhoop K. Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison’s disease. Endocrine 2018;60(2):355-61.10.1007/s12020-017-1513-029388043 Search in Google Scholar

108. Łabuz-Roszak B, Niewiadomska E, Starostka-Tatar A, et al. Multiple sclerosis: oral health, behaviours and limitations of daily oral hygiene - a questionnaire study. Neurol Neurochir Pol 2019;53(4):271-6.10.5603/PJNNS.a2019.003331441495 Search in Google Scholar

109. Walton C, King R, Rechtman L, et al Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 2020;26(14):1816-21.10.1177/1352458520970841772035533174475 Search in Google Scholar

110. Manchery N, Henry JD, Nangle MR. A systematic review of oral health in people with multiple sclerosis. Community Dent Oral Epidemiol 2020;48(2):89-100.10.1111/cdoe.1251231815299 Search in Google Scholar

111. Carvalho LSC, Nascimento OJM, Rodrigues LLFR, et al. Relationship between Expanded Disability Status Scale scores and the presence of temporomandibular disorders in patients with multiple sclerosis. Eur J Dent 2018;12:144-8.10.4103/ejd.ejd_91_17588346729657540 Search in Google Scholar

112. Sexton C, Lalloo R, Stormon N, et al. Oral health and behaviours of people living with Multiple Sclerosis in Australia. Community Dent Oral Epidemiol 2019;47(3):201-9.10.1111/cdoe.1244530618108 Search in Google Scholar

113. Jongen PJ. Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs. CNS Drugs 2017;31(7):585-602.10.1007/s40263-017-0444-x551129828608280 Search in Google Scholar

114. Højsgaard Chow H, Schreiber K, Magyari M, et al. Progressive multiple sclerosis, cognitive function, and quality of life. Brain Behav 2018;8(2):e00875.10.1002/brb3.875582257529484253 Search in Google Scholar

115. Hamza SA, Asif S, Bokhari SAH. Oral health of individuals with dementia and Alzheimer’s disease: A review. J Indian Soc Periodontol 2021;25(2):96-101.10.4103/jisp.jisp_287_20804107133888939 Search in Google Scholar

116. Ming Y, Hsu SW, Yen YY, Lan SJ. Association of oral health-related quality of life and Alzheimer disease: A systematic review. J Prosthet Dent 2020;124(2):168-75.10.1016/j.prosdent.2019.08.01531753458 Search in Google Scholar

117. Plessas A, Paisi M. Is there an association between oral health-related quality of life and Alzheimer’s disease? Evid Based Dent 2020;21:124–5.10.1038/s41432-020-0132-4 Search in Google Scholar

118. Perales J, Cosco TD, Stephan BC, Haro JM, Brayne C. Health-related quality-of-life instruments for Alzheimer’s disease and mixed dementia. Int Psychogeriatr 2013;25(5):691-706.10.1017/S104161021200229323347698 Search in Google Scholar

119. van de Beek M, van Steenoven I, Ramakers IHGB, et al. Trajectories and Determinants of Quality of Life in Dementia with Lewy Bodies and Alzheimer’s Disease. J Alzheimers Dis 2019;70(2):389-97.10.3233/JAD-190041683949731177218 Search in Google Scholar

120. Balash Y, Korczyn AD, Migirov AA, Gurevich T. Quality of life in Parkinson’s disease: A gender-specific perspective. Acta Neurol Scand 2019;140(1):17-22.10.1111/ane.1309530953570 Search in Google Scholar

121. Barbe AG, Bock N, Derman SH, Felsch M, Timmermann L, Noack MJ. Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson’s disease patients. Gerodontology 2017;34(1):135-143.10.1111/ger.1223727231151 Search in Google Scholar

122. Francisconi CF, Caldas RJ, Oliveira Martins LJ, Fischer Rubira CM, da Silva Santos PS. Leukemic oral manifestations and their management. Asian Pac J Cancer Prev 2016;17(3):911-5.10.7314/APJCP.2016.17.3.911 Search in Google Scholar

123. Cella D, Jensen SE, Webster K, et al. Measuring healthrelated quality of life in leukemia: the Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) questionnaire. Value Health 2012;15(8):1051-8.10.1016/j.jval.2012.08.221023244807 Search in Google Scholar

124. Zeng X, Sui M, Liu R, et al. Assessment of the health utility of patients with leukemia in China. Health Qual Life Outcomes 2021;19(1):65.10.1186/s12955-021-01711-1791342833639980 Search in Google Scholar

125. Almeida TM, Cavalcanti ÉF, Freitas AD, Magalhães RJ, Maiolino A, Torres SR. Can dentists detect multiple myeloma through oral manifestations? Hematol Transfus Cell Ther 2018;40(1):43-9.10.1016/j.bjhh.2017.08.006 Search in Google Scholar

126. Delforge M, Minuk L, Eisenmann J, et al. Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide. Haematologica 2015;100(6):826-33.10.3324/haematol.2014.120121445062925769541 Search in Google Scholar

127. Stead ML, Brown JM, Velikova G, et al. Development of an EORTC questionnaire module to be used in healthrelated quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol 1999;104(3):605-11.10.1046/j.1365-2141.1999.01206.x10086801 Search in Google Scholar

128. Proskorovsky I, Lewis P, Williams CD, et al. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health Qual Life Outcomes 2014;12(1):35.10.1186/1477-7525-12-35400782724618388 Search in Google Scholar

129. Golicki D, Jaśkowiak K, Wójcik A, et al. EQ-5DDerived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review. Value Health 2020;23(7):953-68.10.1016/j.jval.2020.04.182532762998 Search in Google Scholar

130. Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin 2015;24(3):491-508.10.1016/j.soc.2015.03.006501820925979396 Search in Google Scholar

131. Abbas S, Tariq MUU, Raheem A, et al. Assessment of Factors Affecting Quality of Life in Oral Squamous Cell Carcinoma Patients Using University of Washington Quality of Life Questionnaire. Cureus 2019;11(1):e3904.10.7759/cureus.3904642454730911459 Search in Google Scholar

132. Yu WY, Waalboer-Spuij R, Bremer R, et al. Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire. Dermatol Surg 2020;46(3):327-34.10.1097/DSS.000000000000204631397784 Search in Google Scholar

133. Mod D, Mod H, Jha A. Oral and dental complications of head and neck radiotherapy and their management. J Nepal Health Res Counc 2013;11(25):300-4. Search in Google Scholar

134. Schwarzinger M, Luchini S, EPICORL Study Group. Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer. Health Qual Life Outcomes 2019;17(1):129.10.1186/s12955-019-1195-9665925131345227 Search in Google Scholar

135. Doward LC, McKenna SP, Whalley D. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68(2):196-200.10.1136/ard.2007.08600918385276 Search in Google Scholar

136. Sansare, K, Kapoor R, Karjodkar F. Validity of Chronic Oral Mucosal Diseases Questionnaire in oral submucous fibrosis. Clin Oral Invest 2019;23:873–7.10.1007/s00784-018-2504-029948274 Search in Google Scholar

137. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96(3):804-10.10.1016/0016-5085(89)90905-0 Search in Google Scholar

138. Wilburn J, McKenna SP, Twiss J, Kemp K, Campbell S. Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ). Qual Life Res 2015;24(9):2279-88.10.1007/s11136-015-0947-125702267 Search in Google Scholar

139. Dorn SD, Hernandez L, Minaya MT, et al. The development and validation of a new coeliac disease quality of life survey (CD-QOL). Aliment PharmTher 2010;31(6):666-75.10.1111/j.1365-2036.2009.04220.x20015103 Search in Google Scholar

140. Speight J, Woodcock AJ, Reaney MD, et al. The ‘QoLQ Diabetes’ – a novel instrument to assess quality of life for adults with type 1 diabetes undergoing complex interventions including transplantation. Diabet Med 2010;27(1):3-4.10.1111/j.1464-5491.2010.03029.x Search in Google Scholar

141. Løvås K, Curran S, Oksnes M, Husebye ES, Huppert FA, Chatterjee VK. Development of a disease-specific quality of life questionnaire in Addison’s disease. J Clin Endocrinol Metab 2010;95(2):545-51.10.1210/jc.2009-171120016050 Search in Google Scholar